REGENERON PHARMACEUTICALSREGENERON PHARMACEUTICALSREGENERON PHARMACEUTICALS

REGENERON PHARMACEUTICALS

No trades
See on Supercharts

1REGN fundamentals

REGENERON PHARMACEUTICALS key financial stats and ratios

1REGN price-to-sales ratio is 7.11. The company has an Enterprise Value to EBITDA ratio of 19.20. As of 2023 they employed 13.45 k people.

Statistics
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: EUR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios